282 related articles for article (PubMed ID: 8758798)
21. [Chemosensitivity assays for malignant gliomas].
Sasaoka N
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2247-52. PubMed ID: 2241189
[TBL] [Abstract][Full Text] [Related]
22. Potential use of the adenosine triphosphate cell viability assay in endometrial cancer.
Tam KF; Ng TY; Tsang PC; Li CF; Ngan HY
J Soc Gynecol Investig; 2006 Oct; 13(7):518-22. PubMed ID: 16979354
[TBL] [Abstract][Full Text] [Related]
23. [A new in vitro chemosensitivity test. Individualized chemotherapy against ovarian cancer and its clinical effect].
Takamizawa H; Sekiya S; Iwasawa H; Ishige H; Tokita H; Tanaka N
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2293-7. PubMed ID: 2416274
[TBL] [Abstract][Full Text] [Related]
24. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.
Moon YW; Choi SH; Kim YT; Sohn JH; Chang J; Kim SK; Park MS; Chung KY; Lee HJ; Kim JH
Cancer; 2007 May; 109(9):1829-35. PubMed ID: 17366594
[TBL] [Abstract][Full Text] [Related]
25. Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: a comparison with cisplatin.
Koshiyama M; Kinezaki M; Uchida T; Sumitomo M
Anticancer Res; 2005; 25(6C):4499-502. PubMed ID: 16334133
[TBL] [Abstract][Full Text] [Related]
26. [Chemosensitivity testing for human ovarian cancer on in vitro colony assay].
Inoue K
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1146-51. PubMed ID: 6471421
[TBL] [Abstract][Full Text] [Related]
27. [A new chemosensitivity test for cancer cells by measuring intracellular ATP content].
Nogaki M; Ichihashi H
Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1950-6. PubMed ID: 3231205
[TBL] [Abstract][Full Text] [Related]
28. [Result of individualized chemotherapy with a newly developed in vitro chemosensitivity testing in ovarian cancer].
Iijima N; Sekiya S; Tokita H; Oosaki T; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1323-8. PubMed ID: 1955784
[TBL] [Abstract][Full Text] [Related]
29. [In vitro drug-resistance decrease of ovarian cancer cells].
Lu SM
Zhonghua Fu Chan Ke Za Zhi; 1990 Nov; 25(6):348-51, 383. PubMed ID: 2282862
[TBL] [Abstract][Full Text] [Related]
30. [The experiment and clinical evaluation of chemosensitivity test for esophageal and gastric cancer by ATP assay using endoscopic biopsy].
Kawano K
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):232-40. PubMed ID: 1513305
[TBL] [Abstract][Full Text] [Related]
31. S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.
He Z; Gao J; Wang Q; Liu M; Li Y; Li X; Tang H; Zheng J
Oncol Rep; 2008 Aug; 20(2):325-32. PubMed ID: 18636193
[TBL] [Abstract][Full Text] [Related]
32. [Enhanced sensitivity of ovarian cell line to cisplatin induced by mifepristone and its mechanism].
Qin TN; Wang LL
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):344-6. PubMed ID: 12390742
[TBL] [Abstract][Full Text] [Related]
33. A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.
Cree IA; Kurbacher CM; Lamont A; Hindley AC; Love S;
Anticancer Drugs; 2007 Oct; 18(9):1093-101. PubMed ID: 17704660
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of cell proliferation and cell death based assays in chemosensitivity testing.
Gerçel-Taylor C; Ackermann MA; Taylor DD
Anticancer Res; 2001; 21(4A):2761-8. PubMed ID: 11724352
[TBL] [Abstract][Full Text] [Related]
35. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples.
Ng TY; Ngan HY; Cheng DK; Wong LC
Gynecol Oncol; 2000 Mar; 76(3):405-8. PubMed ID: 10684718
[TBL] [Abstract][Full Text] [Related]
36. [An evaluation of adenosine triphosphate bioluminescence assay for tumor in vitro chemosensitivity testing].
Liu S; Peng Z; Lou J; Wang H; Tang Q; He B
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):330-3. PubMed ID: 12545824
[TBL] [Abstract][Full Text] [Related]
37. [Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
Chen W; Zhou X; Xu Q; Guo W; Lin L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):404-7. PubMed ID: 12641948
[TBL] [Abstract][Full Text] [Related]
38. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
[TBL] [Abstract][Full Text] [Related]
39. [Expression of lung resistant-related protein in ovarian cancer and its clinical significance].
Qian XL; Peng ZL; Liu SL; Wang H; Ni J
Ai Zheng; 2002 Dec; 21(12):1332-4. PubMed ID: 12520742
[TBL] [Abstract][Full Text] [Related]
40. [Effects of combination chemotherapy of ovarian cancer in vitro].
Lu SM
Zhonghua Yi Xue Za Zhi; 1992 Oct; 72(10):590-2, 638. PubMed ID: 1284340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]